The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
高亲和力抗 IL-6R Nanobody® ALX-0061 的临床前药理学支持其在类风湿关节炎方面的临床开发
期刊:Arthritis Research & Therapy
影响因子:4.4
doi:10.1186/s13075-015-0651-0
Maarten Van Roy, Cedric Ververken, Els Beirnaert, Sven Hoefman, Joost Kolkman, Michel Vierboom, Elia Breedveld, Bert 't Hart, Sofie Poelmans, Lieselot Bontinck, Alex Hemeryck, Sandy Jacobs, Judith Baumeister, Hans Ulrichts
